This Week in Cell

University of California, Los Angeles, and Vanderbilt-Ingram Cancer Center researchers track the genomic and transcriptomic effects of immunotherapy-based treatment for metastatic melanoma in Cell. The team did whole-exome sequencing and/or RNA-sequencing on 38 metastatic melanoma tumors, before and after treatment with pembrolizumab or nivolumab — therapies designed to interfere with the PD-1 immune checkpoint blockade.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.